EBIT at other companies
Other financials
Where this comes from
Calculated from Citius Oncology, Inc.’s reported figures.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s EBIT?
- Citius Oncology, Inc. (CTOR) reported EBIT of -$28.61M in Q1 2026.
- How has Citius Oncology, Inc.'s EBIT changed year-over-year?
- Citius Oncology, Inc.'s EBIT decreased by 283.0% year-over-year, from -$7.47M to -$28.61M.
- What is the long-term trend for Citius Oncology, Inc.'s EBIT?
- Over 2 years (2023 to 2025), Citius Oncology, Inc.'s EBIT has grown at a 148.8% compound annual growth rate (CAGR), from -$3.8M to -$23.52M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.